Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin, Christine Johnston, Richard E. Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert W. Frenck Jr., Martín Bäcker, Angelica C. Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobryzynski, Christine M. Posavad, Janet I. Archer, Sonja Crandon, Seema U. Nayak, Daniel Szydlo, Jillian Zemanek, Clara P. Dominguez Islas, Elizabeth R. Brown, Mehul S. Suthar, M. Juliana McElrath, Adrian B. McDermott, Sarah E. O’Connell, David C. Montefiori, Amanda Eaton, Kathleen M. Neuzil, David S. Stephens, Paul C. Roberts, John H. Beigel, the DMID 21-0012 Study Group
doi: https://doi.org/10.1101/2021.10.10.21264827

Article Information

doi 
https://doi.org/10.1101/2021.10.10.21264827
History 
  • October 15, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Robert L. Atmar, M.D.*,1,#,
  2. Kirsten E. Lyke, M.D.*,2,#,
  3. Meagan E. Deming, M.D., Ph.D.3,
  4. Lisa A. Jackson, M.D., M.P.H.4,
  5. Angela R. Branche, M.D.5,
  6. Hana M. El Sahly, M.D.6,
  7. Christina A. Rostad, M.D.7,
  8. Judith M. Martin, M.D.8,
  9. Christine Johnston, M.D., M.P.H.9,
  10. Richard E. Rupp, M.D.10,
  11. Mark J. Mulligan, M.D.11,
  12. Rebecca C. Brady, M.D.12,
  13. Robert W. Frenck Jr., M.D.12,
  14. Martín Bäcker, MD14,
  15. Angelica C. Kottkamp, M.D.15,
  16. Tara M. Babu, M.D., M.S.C.I.16,
  17. Kumaravel Rajakumar, M.D., M.S.8,
  18. Srilatha Edupuganti, M.D., M.P.H.18,
  19. David Dobryzynski, M.D.5,
  20. Christine M. Posavad, Ph.D.20,
  21. Janet I. Archer, M.Sc.21,
  22. Sonja Crandon, B.S.N.22,
  23. Seema U. Nayak, M.D.22,
  24. Daniel Szydlo, M.S.23,
  25. Jillian Zemanek, M.P.H.24,
  26. Clara P. Dominguez Islas, Ph.D26,
  27. Elizabeth R. Brown, Sc.D.26,
  28. Mehul S. Suthar, Ph.D.28,
  29. M. Juliana McElrath, M.D., Ph.D.29,
  30. Adrian B. McDermott, Ph.D.30,
  31. Sarah E. O’Connell, M.S.30,
  32. David C. Montefiori, Ph.D.32,
  33. Amanda Eaton, M.B.A.33,
  34. Kathleen M. Neuzil, M.D.3,
  35. David S. Stephens, M.D.35,
  36. Paul C. Roberts, Ph.D.22,
  37. John H. Beigel, M.D.22,
  38. the DMID 21-0012 Study Group**
  1. 1Departments of Medicine and Molecular Virology & MIcrobiology, Baylor College of Medicine, Houston, TX 77030
  2. 2Center for Vaccine Development and Global Health collaborating with the Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
  3. 3Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201
  4. 4Kaiser Permanente Washington Health Research Institute, Seattle, WA
  5. 5Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY 14642
  6. 6Departments of Molecular Virology & MIcrobiology and Medicine, Baylor College of Medicine, Houston, TX 77030
  7. 7Department of Pediatrics and Center for Childhood Infections and Vaccines, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA 30322
  8. 8Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213
  9. 9Departments of Medicine and Laboratory Medicine, University of Washington, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98104
  10. 10Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555
  11. 11NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY 10016
  12. 12Cincinnati Children’s Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45229-3039
  13. 14NYU Langone Hospital—Long Island Vaccine Center Research Clinic and Division of Infectious Disease, Department of Medicine, NYU Long Island School of Medicine, Mineola, NY 11501
  14. 15NYU Langone Vaccine Center Bellevue Hospital Research Clinic and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY 10016
  15. 16Department of Medicine, University of Washington, Seattle, WA 98104
  16. 18Division of Infectious Diseases, Department of Medicine, Hope Clinic of Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30030
  17. 20Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA
  18. 21FHI360, Durham, NC 27701
  19. 22Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
  20. 23Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA_98109
  21. 24Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA 98109
  22. 26Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
  23. 28Emory Vaccine Center, Yerkes National Primate Research Center; Department of Pediatrics; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA
  24. 29Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; Department of Medicine and Laboratory Medicine and Pathology, University of Washington, Seattle, WA
  25. 30Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
  26. 32Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center, Durham, NC
  27. 33Department of Surgery, Duke University Medical Center, Durham, NC
  28. 35Department of Medicine, Emory University, Atlanta, GA
  1. ↵#Corresponding Authors:
    Robert L. Atmar, M.D., 1 Baylor Plaza, MSBCM280, Houston, TX 77030, Phone: +1 713-798-6849, Email: ratmar{at}bcm.edu, Kirsten E. Lyke, M.D., Center for Vaccine Development and Global Health, 685 W. Baltimore Street, Baltimore, MD 21201, Phone: +1 410-706-0462/5328, Email: klyke{at}som.umaryland.edu

  1. ↵* Authors contributed equally to the work

Back to top
Posted October 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin, Christine Johnston, Richard E. Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert W. Frenck Jr., Martín Bäcker, Angelica C. Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobryzynski, Christine M. Posavad, Janet I. Archer, Sonja Crandon, Seema U. Nayak, Daniel Szydlo, Jillian Zemanek, Clara P. Dominguez Islas, Elizabeth R. Brown, Mehul S. Suthar, M. Juliana McElrath, Adrian B. McDermott, Sarah E. O’Connell, David C. Montefiori, Amanda Eaton, Kathleen M. Neuzil, David S. Stephens, Paul C. Roberts, John H. Beigel, the DMID 21-0012 Study Group
medRxiv 2021.10.10.21264827; doi: https://doi.org/10.1101/2021.10.10.21264827
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area